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Metal-Specific Biomaterial Accumulation in Human
Peri-Implant Bone and Bone Marrow
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Metallic implants are frequently used in medicine to support and replace
degenerated tissues. Implant loosening due to particle exposure remains a
major cause for revision arthroplasty. The exact role of metal debris in sterile
peri-implant inflammation is controversial, as it remains unclear whether and
how metals chemically alter and potentially accumulate behind an insulating
peri-implant membrane, in the adjacent bone and bone marrow (BM). An
intensively focused and bright synchrotron X-ray beam allows for spatially
resolving the multi-elemental composition of peri-implant tissues from
patients undergoing revision surgery. In peri-implant BM, particulate cobalt
(Co) is exclusively co-localized with chromium (Cr), non-particulate Cr
accumulates in the BM matrix. Particles consisting of Co and Cr contain less
Co than bulk alloy, which indicates a pronounced dissolution capacity.
Particulate titanium (Ti) is abundant in the BM and analyzed Ti nanoparticles
predominantly consist of titanium dioxide in the anatase crystal phase. Co
and Cr but not Ti integrate into peri-implant bone trabeculae. The
characteristic of Cr to accumulate in the intertrabecular matrix and trabecular
bone is reproducible in a human 3D in vitro model. This study illustrates the
importance of updating the view on long-term consequences of biomaterial
usage and reveals toxicokinetics within highly sensitive organs.
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1. Introduction
Modern arthroplasty implants enable pain-
less mobility and ensure significant im-
provement of life quality. A stable in-
tegration of the artificial joint in the
peri-implant mineralized tissue is crucial
for its success. Materials used in arthro-
plasty are of multi-elemental composition
to ensure long-term mechanical stabil-
ity of the implant.[1] Cobalt–chromium–
molybdenum (CoCrMo) alloys, aluminum
(Al) based ceramics and polyethylene are
widely used for articulating components
of total knee arthroplasty (TKA) and total
hip arthroplasty (THA) implants. Titanium
(Ti) alloys, such as titanium-aluminum-
vanadium (TiAlV), are most often used as
base materials for load-bearing and stabi-
lizing implant components.[2] In revision
arthroplasty, the elemental diversity is even
more pronounced due to additional stabi-
lizing components such as porous tanta-
lum (Ta), which can compensate for insuffi-
cient bone integrity. Moreover, poly(methyl
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methacrylate) contains radiopacity enhancing zirconium dioxide
(ZrO2) particles and is often used as orthopedic cement to fix im-
plants in peri-implant cancellous bone.
Despite the overall success of arthroplasty, local and systemic
complications caused by release of metallic wear and corrosion
products remain problematic.[3,4] Pairing CoCrMo alloys as ar-
ticulating components of hip implants turned out to be unfa-
vorable which is indicated by comparatively short primary im-
plant survival strongly linked to the release of metallic nanopar-
ticles and ions.[5-8] The characteristics of local adverse effects
highly depend on the elemental composition and physicochemi-
cal properties of the released particles.[9] Recently, it was shown
that metal species are highly diverse in the peri-implant mem-
brane of metal-on-metal (MOM) hip implants.[10] The diversity
of metal speciation will even be more pronounced in the future
due to recent advances in nanosized surface modifications of
materials used for biomedical applications.[11] While the ex vivo
exposure assessment of metals released from implants with ar-
ticulating metal surfaces is commonly described in literature,
the steady release of metal wear debris from surfaces of load-
bearing but non-articulating implant components is largely dis-
regarded. This is particularly surprising, since histopathologi-
cal examinations of the synovia-like peri-implant membrane re-
veal a comprehensive variety of metallic wear and corrosion
products locally released from non-articulating components of
THA implants.[12] Load-bearing components have direct contact
with adjacent cancellous bone structures and the bone marrow
(BM) of patients at early post-operative stages. During the post-
operative course, non-biomimetic metal-based materials induce a
foreign body reaction, which results in encapsulation of the com-
ponents by a collagen-rich peri-implant membrane with insulat-
ing properties.[13] Local exposure has mostly been studied in the
peri-implant membrane and synovial fluid, but not comprehen-
sively in the adjacent bone and BM.
Recent investigations suggest that the complex immune
cell composition of the BM, and its capability to host adaptive
immune cells, plays a crucial role in the development of metal
exposure induced inflammation.[14] A functional BM homeosta-
sis is essential for human health, not only to constantly generate
hematopoietic cells, but also for providing bone progenitor
cells.[15,16] Unbalanced bone and BM tissue homeostasis is as-
sociated to various long-term consequences like stress shielding
induced periprosthetic osteopenia, periprosthetic fractures, oste-
olysis, and associated implant loosening.[17–19] It is assumed that
this is due to a local pro-inflammatory environment resulting
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from particle exposure in the peri-implant membrane which
leads to increased osteoclastic and diminished osteoblastic differ-
entiation and activity.[20,21] Recent ex vivo and in vitro studies pro-
vide evidence that metal exposure may directly affect osteoclasts
and osteoblasts (OBs).[22–24] Previous studies detected supraphys-
iological non-particulate Co and Cr levels in the peri-implant BM
of patients with MoM articulation. These supraphysiological lev-
els were associated with a loss of osteogenic capacity of human
BM mesenchymal stromal cells (hMSCs), which implicated Co
and Cr as being involved in the pathogenesis of peri-implant
bone loss.[25] Yet, the toxicokinetics and toxicodynamics of
the various metallic degradation products and their potential
accumulation in peri-implant bone and BM remain elusive.
The hypothesis of this work is that particulate as well as
dissolved metals released from arthroplasty implants are not
fully isolated by the peri-implant membrane but are abundantly
present in peri-implant cancellous bone and intertrabecular BM.
Using a unique synchrotron-based X-ray fluorescence (XRF)
imaging setup, this study aims to qualitatively and quantitatively
analyze the local toxicokinetics of released metallic wear and cor-
rosion products and to identify their specific spatial distribution
in bone and BM. Such an approach allows, for the first time, to
analyze if metallic degradation products show a specific spatial
distribution or uptake in human peri-implant bone and BM on a
micron- and nanoscale.
2. Results
2.1. Study Design and Experimental Strategy
In order to perform spatially resolved multi-metal exposure as-
sessment, 10 µm sections of peri-implant cancellous bone includ-
ing intertrabecular BM from 14 patients with different loosened
knee and hip implants were analyzed by synchrotron micro- and
nano-XRF imaging. Corresponding specimens from six patients
undergoing primary arthroplasty served as controls (Table 1).
Peri-implant samples were intraoperatively harvested from close
proximity to the implant and control samples were collected from
the metaphyseal medullary cavity during primary implantation
(Figure 1A). For orientation during XRF-mapping and for the def-
inition of regions of interest (ROI), hematoxylin and eosin (H&E)
stainings were performed on the sections adjacent to the sections
used for XRF-scans (Figure 1B). The general XRF-scanning strat-
egy was based on large fields of view micro-XRF analyses, per-
formed at the ID21 beamline with step size of 30 µm, for obtain-
ing an overall picture of the metal distribution in cancellous bone
and intertrabecular BM (Figure 1C). Thus, ROIs for mapping at
higher resolution were defined from these overview maps and
from histological evaluation. Criteria for ROI definition were fo-
cal metal exposure as well as the presence of biological alterations
like osteolysis of cancellous bone, fibrous and inflammatory or
necrotic changes within the marrow structures. Scans were per-
formed over these ROIs at medium resolution (10, 3, and 2 µm)
and quantitative mass fraction maps were calculated in whole
scans or in specific areas of these maps (Figure 1D). Samples
were then transferred to the nanoprobe ID16B. There, nano-XRF
mapping was performed on ROIs defined on medium-resolution
maps. For orientation purpose, an overview scan was performed
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Table 1. Sample list, location of intraoperative sample extraction, and quantitative comparison of the individual samples regarding Co, Cr, and Ti content.
Percentage of spatial mass fraction greater than background spatial mass fractions (= Q0.999 of all pixel intensities from control samples) and maximum
spatial mass fractions of Co, Cr, and Ti. Data were obtained from all XRF-scans with 2–10 µm spatial resolution.
Sample ID Revised implant Sample location n > Q0.999 [%] Max value [wt%]
Co Cr Ti Co Cr Ti
Control 1 - (native) Femoral 0.31 0.12 0.02 0.04 0.47 0.11
Control 2 - (native) Femoral 0.08 0.03 0.23 0.11 0.07 11.4
Control 3 - (native) Femoral 0.19 0.01 0.00 0.02 0.01 0.05
Control 4 - (native) Femoral 0.00 0.13 0.04 0.01 0.03 0.18
Control 5 - (native) Femoral 0.00 0.28 0.05 0.02 0.51 0.20
Control 6 - (native) Femoral 0.01 0.02 0.06 0.02 0.01 0.10
Case 1 Modular stem THA implant Not classifiable 15.9 13.0 0.26 9.71 3.97 1.31
Case 2 Modular stem THA implant Femoral 12.3 7.09 0.09 4.93 3.24 6.19
Case 3 Hip resurfacing implant Acetabular 35.0 76.0 0.04 3.43 12.8 4.75
Case 4 Hip resurfacing implant Not classifiable 25.4 49.9 0.01 1.80 6.19 0.18
Case 5 Hip resurfacing implant Acetabular 2.85 98.2 0.04 0.89 2.17 0.55
Case 5 Hip resurfacing implant Femoral 0.18 14.2 0.74 0.24 1.31 38.0
Case 6 Hip resurfacing implant Acetabular 8.56 20.3 0.03 5.18 2.56 0.15
Case 6 Hip resurfacing implant Femoral 0.23 0.61 0.94 0.55 1.04 0.36
Case 7 Primary THA implant Acetabular 0.04 5.49 0.22 0.05 6.76 0.40
Case 8 Primary THA implant Femoral 1.36 0.07 0.02 0.08 0.09 0.51
Case 9 Primary THA implant Acetabular 0.14 1.60 9.21 1.50 0.53 48.4
Case 10 Primary THA implant Femoral 1.63 1.47 2.00 2.82 1.17 32.9
Case 11 Multi-component revision THA implant Acetabular 0.44 0.70 0.25 0.24 1.41 5.53
Case 12 Multi-component revision THA implant Acetabular 0.79 0.44 4.78 0.49 2.15 30.9
Case 13 Primary TKA implant Femoral 0.21 0.62 0.13 0.41 0.54 5.62
Case 14 Primary TKA implant Tibial 41.5 59.2 0.00 3.61 4.12 0.29
Case 14 Primary TKA implant Femoral 31.2 61.1 0.11 3.46 3.24 0.32
with steps of 1 µm before scanning at resolutions of 60 and 30 nm
(Figure 1E).
2.2. Identification of the Overall Exposure: Metal Mass Fractions
in Analyzed Samples
For all samples analyzed, the underlying clinical case and sec-
ondary patient characteristics including implant data (Table S1,
Supporting Information), prerevisonal radiographs (Figure S1,
Supporting Information) and, if available in clinical records, lo-
cal and systemic metal levels (Table S2, Supporting Information)
are reported.
The nano- and micron-resolved XRF-analyses revealed that
metals released from endoprostheses are abundantly present in
acetabular, femoral, and tibial peri-implant cancellous bone in-
cluding BM with Co, Cr, and Ti particles of various sizes and
shapes dominating the overall metal exposure. Supraphysiologi-
cal metal quantities were identified in specimens from the prox-
imity of various hip and knee endoprostheses independent of
their specific design. Distinct regions within the samples con-
tained metal mass fractions up to a double-digit percentage.
Other particulate metals like (zirconium) Zr and Ta were detected
in individual cases. In order to benchmark the overall Co, Cr,
and Ti contents of native (control) and peri-implant samples, data
points (mass fractions of each pixel) from scans with a spatial
resolution of 2–10 µm were combined for each of the individual
sample. All data points obtained from control samples were sum-
marized to calculate the element-specific upper 99.9% quantile
(Q0.999). All data points below these upper Q0.999 of the control
samples were defined as physiological background levels. Plot-
ting of all data points revealed that supraphysiological Co, Cr,
and Ti signals were highly abundant in peri-implant samples of
all implant types (Figure 2). The relative amount of spatial mass
fraction signals greater than Q0.999 as well as higher maximum
spatial mass fractions also indicate supraphysiological quantities
of these metals in peri-implant samples compared to controls (Ta-
ble 1). The distributions of the quantitative data points for Co, Cr,
and Ti of all individual nano-XRF maps with spatial resolution of
60 nm are provided in Figure S2, Supporting Information.
2.3. Specificity of the Spatial Distribution: Metal Exposure in
Bone Marrow
The overall multi-elemental mass fraction analyses of peri-
implant specimens revealed substantial exposure to Co, Cr, and
Ti (Table 1). To obtain an overall picture of the spatial frequency
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Figure 1. Representative experimental strategy for the spatially resolved multi-metal exposure assessment by means of synchrotron micro- and nano-XRF
analyses of peri-implant bone and BM. A) Cancellous bone including BM was intraoperatively harvested from close proximity to arthroplasty implants
and from patient without implant as indicated by red areas in the depicted preoperative X-ray radiographies. B) Representative image of a harvested
specimen and H&E staining of peri-implant cancellous bone including BM from a patient with hip resurfacing implant. C) Corresponding RGB (red:
Ca, green: Co, blue: Cr) qualitative micro-XRF maps in ascending order of resolution. Full image (30 µm spatial resolution), yellow rectangle (10 µm
spatial resolution), pink rectangle (2 µm spatial resolution). D) Quantitative heat-map of Cr weight fractions in the 2 µm resolved micro-XRF map and an
averaged XRF-spectrum of marrow structures indicating predominant exposure to Co and Cr. E) RGB (red: Zr, green: Co, blue: Cr) qualitative nano-XRF
map with a spatial resolution of 60 nm indicating exposure to metal particles at various sizes and shapes.
and quantity of metals in BM from the proximity of different im-
plant setups, XRF-maps with a resolution of 2 µm were analyzed
with regard to spatial element distribution (Figure 3). Accord-
ing to surgical reports, the cancellous bone samples including
intertrabecular BM were intraoperatively collected in close prox-
imity to the implant (Figure 3A) but distal to the peri-implant
membrane.
Qualitative iron (Fe) and sulfur (S) mapping indicates the pres-
ence of intertrabecular matrix and reveals variation regarding
spatial distribution of these elements in the different samples.
Qualitative mapping of the XRF-scans from the control sam-
ple shows BM matrix-specific physiological Co signals. Implant-
related metal exposure in peri-implant BM samples was found
to be dominated by Co, Cr, and Ti (Figure 3B). Quantitative fre-
quency analyses of the Co, Cr, and Ti signals showed magni-
tudes higher mass fractions in the intertrabecular BM if com-
pared to control (Figure 3C). Co and Cr were predominantly de-
tected in peri-implant intertrabecular BM from patients with hip
resurfacing implant, TKA implant and modular THA implant.
In contrast, detected Ti exposure was most dominant in patients
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Figure 2. Distributions of the spatial mass fractions of Co, Cr, and Ti obtained from multi-elemental XRF-mapping. Depicted are all data points from
maps with 2–10 µm spatial resolution which are greater than the metal specific 99.9% quantile of the overall data points obtained from the control
samples (Q0.999 Co, 0.018 wt%; Q0.999 Cr, 0.011 wt%; Q0.999 Ti, 0.052 wt%). Data points from individual maps of the same samples were combined.
Abbreviations: nc, sample location not classifiable; f, femoral; a, acetabular; t, tibial.
with multi-component revision THA implant and in femoral
samples of patients with primary THA implant. In summary,
peri-implant BM is exposed to metals released from arthroplasty
implants of various designs.
2.4. Characteristics of Cobalt and Chromium Exposure in Bone
Marrow
XRF-overview maps indicate that intertrabecular BM samples
harvested in proximity to hip resurfacing implants and TKA im-
plants are exposed to Co and Cr at the time of revision (Table 1).
In-depth analyses of these exposure scenarios were performed to
resolve particle characteristics and locations of these two metals
in the peri-implant BM.
To this end, regions of intertrabecular BM from the proxim-
ity of both implant types were chosen from histological stain-
ings (Figure 4A). Already at spatial micron resolutions (2 µm),
it was found that Cr is highly abundant and homogenously dis-
tributed throughout the BM matrix structures, whereas Co was
only focally detected (Figure 4B). Plotting of the spatial Co and Cr
mass fractions obtained from the 2 µm resolved scans revealed
that particles containing Co are exclusively co-localized with Cr,
whereas Cr was also detected without Co at high abundance (Fig-
ure 4C). To elucidate whether Cr accumulates within extracellular
matrix or cellular structures of the marrow, the co-localization of
Cr with sulfur (S) and phosphorus (P) was investigated. S is a
generally accepted indicator for extracellular matrix, while P is
more specific for cellular structures. These low Z-elements are
detectable in the course of micro-XRF analyses under vacuum
conditions. Plotting of the spatial mass fractions indicated a dis-
tinct co-localization of Cr with P (Figure 4D) and S (Figure 4E)
within the analyzed peri-implant BM of both implant types. No-
tably, Cr was exclusively detected co-localized with S and P, in-
dicating pronounced binding affinity of the released Cr to BM
matrix and cellular structures. The Cr content within the P- and
S-rich data points are statistically significant higher if compared
to the Co content in these data points (Figure 4F). This finding
confirms the distinct co-localization of Cr with P and S and in-
dicates that Co does not manifest a local affinity for matrix bind-
ing. Since most particles released from arthroplasty implants are
known to be significantly smaller than 2 µm, nanoresolved anal-
yses were performed to confirm the metal-specific distribution
patterns. XRF-scans at 60 nm resolution show substantial expo-
sure to CoCr containing micron-, submicron- and nanoparticles,
confirm the distinct co-localization of both metals and reveal dis-
solution clouds of Cr as characteristic distribution pattern of this
metal (Figure 4G). These specific distribution patterns were ob-
served in all Co and Cr exposed peri-implant BM samples (Figure
S3, Supporting Information). The homogenous distribution of
Cr throughout the entire BM matrix becomes even more evident
at a 30 nm resolution (Figure 4H). Cr was found to be present
in the non-particulate state and thus most likely to be covalently
bound to matrix and cellular structures. The quantitative aver-
aged XRF-spectra of corresponding regions indicated that Cr, but
not Co, is exclusively abundant in areas without submicron and
nanoparticles. On the other hand, the detected particles exclu-
sively contain both metals (Figure 4G,H). Nano-XRF imaging of
CoCr particles revealed Co and Cr containing particle cores and
Cr containing particle coronas. Quantification of the Co and Cr
content of particles in the peri-implant BM from patients with
different endoprostheses, revealed ratios that did not reflect the
ratios of the bulk CoCrMo alloy (Figure 4I). In bulk CoCrMo alloy,
the Co to Cr ratio is stated to be approximately 2:1, whereas the Co
to Cr ratios in the analyzed particles were found to be 1:1 to 1:2.
Taken together, more Co than Cr is released from peri-impant
particles, but Cr has a distinct binding affinity to BM matrix
structures.
2.5. Exposure to Metals from Non-Articulating Components
Beside the distinct exposure to Co and Cr, an unexpected find-
ing of this study is the pronounced Ti exposure in all analyzed
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Figure 3. Co, Cr, and Ti were abundantly detected in peri-implant bone marrow from various implant types and locations. A) Preoperative X-ray radio-
graphies. Red areas indicate the site of sample extraction. B) Qualitative RGB image sections of micro-XRF maps with a resolution of 2 µm. Fe and S
indicate matrix structures of the marrow. Mapping of Co, Cr, and Ti indicates the widespread dissemination of these metals in peri-implant BM. Bright-
ness and contrast of the RGB images were adjusted to represent the individual minimum and maximum amplitude of the signal. Scales are therefore
not comparable from one sample to another. C) Frequency distributions of quantified mass fractions of each individual map and element indicate sup-
raphysiological signals of Co, Cr, and Ti if compared to control (bin width [wt%]: Co, 0.1; Cr, 0.1; Ti, 0.5). Abbreviations: THA, total hip arthroplasty; TKA,
total knee arthroplasty.
peri-implant BM samples. The highest quantities of Ti particles
were detected in the femoral surroundings of patients with THA
implant and the acetabular surrounding of patients with revision
THA implants (Figure 3). Even BM samples from the proxim-
ity of implants with relatively small Ti components, such as hip
resurfacing implants or TKA implants, contain supraphysiologi-
cal amounts of Ti (Table 1).
In the course of investigating the distribution, accumulation,
and chemical speciation of Ti particles in these samples, it was
noticed that the highest number of particles occur in tissue-
altered regions of the BM (Figure 5A). These samples were char-
acterized by highly osteolytic bone as well as fibrotic and necrotic
BM. Extensive quantities of Ti micro-, submicron- and nanopar-
ticles were not only detected in fibrotic BM areas of the acetabu-
lar surrounding of a patient with multi-component revision THA
implant, but also in pronouncedly necrotic regions in proximity
to a Ti stem of a THA implant (Figure 5A). In the latter case,
nanoresolved XRF-imaging revealed the presence of micron- and
nanoscale Ti-containing particles (Figure 5B). Averaged nano-
XRF spectra showed that micron-sized Ti particles contain sin-
gle digit percentage concentrations of alloy constituents such
as iron and Cr. In contrast to the micron-sized particles, Ti-
containing nanoparticles contain almost no traces of other metals
(Figure 5B). Within necrotic tissue, nano- and micron-sized par-
ticles were detected intra- and extracellularly in a focal inflam-
matory region with residual BM-like structure (Figure 5C). In
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Figure 4. Non-particulate Cr accumulates in BM matrix whereas Co was only found in the particulate state and co-localized with Cr. A) H&E stainings
of intertrabecular BM from the proximity of a hip resurfacing implant and a knee endoprostheses. B) Corresponding 2 µm resolved XRF-maps of
intertrabecular BM. The qualitative RGB imaging reveals spacious distribution of Cr and focal hotspots of Co co-localized with Cr. C) Scatter dot plots
of the Co and Cr special mass fractions (areas depicting cancellous bone were excluded, dashed lines) indicate that Co is exclusively co-localized while
Cr is also solitary detected in the BM. D) Scatter dot plots of the Co and P (red) and Cr and P (green) mass fractions indicate distinct co-localization
of Cr with P. E) Scatter dot plots of the Co and S (red) and Cr and S (green) mass fractions indicate distinct co-localization of Cr with S. F) Cr versus
Co mass fractions in P- and S-rich data points by means of the upper 10% of data points regarding their S and P content. (Hip resurfacing: n = 22510
each group, primary TKA: n = 2853 each group; Mann–Whitney test (two-sided); **** p < 0.001). G) Qualitative RGB imaging of nanoresolved (60 nm)
XRF-maps confirms the distinct deposition of Cr in the marrows’ matrix. Co and Cr containing particles of various sizes and shapes are abundantly
represented in peri-implant BM. H) Quantitative XRF-heat maps at 30 nm resolution show non-particulate Cr. Analyses of the according XRF-spectra
clearly demonstrate that the particles consist of both, Co and Cr, whereas areas of non-particulate Cr do not contain Co. I) Quantification of Co and
Cr contents of particles detected in the BM from a knee endoprosthesis (tibial, see (F)), knee endoprosthesis (femoral), hip resurfacing implant and a
modular stem hip endoprosthesis (left to right) reveals lower Co:Cr ratios if compared to the bulk alloy. Stated numbers reflect the mass ratios of Co
and Cr within the analyzed particles (dashed rectangles). Abbreviation: TKA, total knee arthroplasty.
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Figure 5. Exposure to particles from non-articulating implant components in altered BM matrix. A) From left to right: Highly osteolytic bone remains
and necrotic tissue from the femoral site of a patient with primary THA implant. Osteolytic bone and fibrotic marrow structures from a patient with
failed revision THA implant. Highly osteolytic bone and inflammatory BM from a patient undergoing revision of a failed multi-component revision THA
implant. BM from the surrounding of a TKA implant is characterized by slightly fibrotic regions. 2 µm resolved XRF-scanning and resulting heatmaps
reveal extensive loads of Ti particles in necrotic and fibrotic zones. B) Nanoresolved analysis revealed micron- and nanosized Ti particles. Averaged
XRF-spectra reveal that Ti nanoparticles contain only traces of constituent alloy metals. C) Nanoresolved analysis of an inflammatory center reveals an
enormous intra- and extracellular multi-metal particle load. Size and shape of the depicted cell suggest the occurrence of a macrophage driven response.
D) TiO2 particles within the BM from the tibial surrounding of a primary TKA implant. Qualitative imaging of submicron-resolved (500 nm) XRF-maps
depict the presence of Ti within the analyzed sample section. Analysis of the averaged XRF-spectra clearly demonstrates that the particles consist of
Ti. Comparison of the resulting micro-XANES absorption spectrum to previously measured spectra from TiO2 in the rutile and anatase phase clearly
demonstrate a dominate anatase crystal proportion. Abbreviations: THA, total hip arthroplasty; TKA, total knee arthroplasty.
this sample from a patient who experienced a severe failure of
a revision THA implant due to screw fracture and wear-out of a
cemented non-articulating but load bearing trabecular Ta compo-
nent, other metals than Ti like Zr and Ta were detected at high
abundance. The identified cell within the inflammatory region
fits the criteria for being a macrophage in terms of size and shape.
It is generally accepted that chronic innate immune responses
due to extensive particle load can lead to fibrotic and necrotic tis-
sue changes.
Areas containing Ti particles were analyzed by micro X-ray ab-
sorption near edge structure (micro-XANES) spectroscopy since
potential biological effects highly depend on the chemical and
structural state of particles (Figure 5D). To this end, the peri-
implant BM of a patient undergoing revision of a TKA implant
was analyzed by multi-elemental XRF-mapping to localize the Ti-
containing particles and to subsequently characterize the identi-
fied particles by micro-XANES. The XANES spectra of the ana-
lyzed Ti particles (n = 5) show a characteristic which is consis-
tent with spectra of titanium dioxide (TiO2). Crystal phases of
TiO2 like the most frequent rutile and anatase, differ in their
potency for inducing an inflammatory response. The compari-
son to rutile and anatase reference XANES spectra, clearly shows
that the TiO2 dominantly occurs in the anatase crystal phase. A
linear combination fitting of the generated spectra indicates that
anatase is the predominant crystal phase of the analyzed TiO2
particles (Figure S2, Supporting Information). Collectively, the
micron- and nano-XRF analyses and micro-XANES spectroscopy
provide evidence for the release of metals, especially Ti, from
non-articulating implant components into the adjacent BM. In an
inflammatory region, particles of multi-metal composition can be
found intracellular. Ti particles released from knee endoprosthe-
ses consist of TiO2 with dominant proportions of the compara-
tively pro-inflammatory anatase crystal phase.
2.6. Metal Integration into Peri-Implant Cancellous Bone
Since the obtained analyses revealed significant metal expo-
sure within intertrabecular BM, it was subsequently investigated
whether and to what extend metals integrate into cancellous
bone. Maps with 2 and 10 µm spatial resolution containing bone
trabeculae were analyzed (Figure 6). Threshold levels of the cal-
cium (Ca) content were defined for assigning the individual data
points to trabecular bone. Data points with a Ca content greater
than 1 wt% and less than 20 wt% were defined as trabecular edge
(TbE) regions. Data points with a Ca content greater than 20 wt%
were defined as trabecular core (TbC) regions.
Concentrations of Co, Cr, and Ti were found to be several
orders of magnitude higher in peri-implant TbE regions than
in control samples. While Co and Cr were abundantly present
in TbE regions of all peri-implant samples, Ti exposure in
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Figure 6. Co and Cr integrate into peri-implant cancellous bone. A) The distributions of quantitative data points for Co, Cr, and Ti in trabecular edge
regions (1–20 wt% Ca) and trabecular core regions (>20 wt% Ca) of micro-XRF maps from peri-implant cancellous bone samples. Blue lines indicate the
upper 99.9% quantile of all control samples. B) Linear regression of maximum metal mass fractions. Two-tailed Pearson correlation coefficient analyses
(trabecular edge: Co, n = 32; Cr, n = 32; Ti, n = 32 and trabecular core: Co, n = 30; Cr, n = 30; Ti, n = 29). C) Quantitative heat maps of micro-XRF scans
(2 µm spatial resolution) of native cancellous bone, and peri-implant cancellous bone samples. From left to right: quantitative Ca maps, spatial view of
thresholding of the different regions regarding Ca content, quantitative Co and Cr maps. D) Co integration into intact peri-implant cancellous bone. Top
left to bottom right: qualitative image of a micro-XRF map (5 µm spatial resolution), averaged micro-XRF spectra of a region indicative of low Co content
(d1) and high Co content (d2), quantitative Ca (d3), and Co (d4) heatmaps of micro-XRF scans (1 µm spatial resolution) indicates gradual Co integration.
Abbreviations: TbE, trabecular edge; TbC, trabecular core; iTbS, intertrabecular space; THA, total hip arthroplasty; TKA, total knee arthroplasty.
peri-implant TbE regions was dependent on the implant type and
was generally less pronounced and especially low in samples ob-
tained from TKA implants. In TbC regions, no significant expo-
sure to Ti was detected, whereas Co and Cr also integrated into
peri-implant TbC regions, particularly into peri-implant trabecu-
lae of hip resurfacing implants and modular THA implants (Fig-
ure 6A). The integration of Co and Cr into peri-implant trabec-
ulae was further confirmed by regression analyses of metal con-
tents in the intertrabecular space (iTbS) and in the trabeculae.
This analysis revealed a statistically significant positive correla-
tion between maximum mass fractions of Co and Cr in the iTbS
and both regions (TbE and TbC) of the trabeculae. Accordingly,
no correlation was found between the maximum mass fractions
of Ti in iTbS and TbC regions, confirming that Ti is not inte-
grated into intact peri-implant trabeculae (Figure 6B). Analyses of
spatially resolved quantitative heat maps of trabeculae from the
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proximity of a hip resurfacing implant and a modular THA im-
plant indicate that Cr is rather focally present, particularly in TbE
regions, and not consistently distributed in TbC regions. In con-
trast, a uniform distribution of Co in peri-implant trabeculae in-
dicates its pronounced integration affinity (Figure 6C). Spatially
resolved maps of intact femoral bone trabeculae in close proxim-
ity to a THA implant illustrate the onset of Co integration, which
is characterized by gradual integration from TbE regions to TbC
regions (Figure 6D). Taken together, the BM and cancellous bone
analyses show that Co and Cr integrate into peri-implant cancel-
lous bone and their maximum concentrations strongly correlate
with those found in intertrabecular BM. In contrast, even in cases
of very pronounced Ti exposure within intertrabecular BM, there
is no Ti integration into the trabecular core.
2.7. Validation of the Metal-Specific Distribution: Bone/Bone
Marrow-on-a-Chip
Multi-metal XRF-analyses showed that Co and Cr integrate into
peri-implant cancellous bone in a non-particulate state and that
Cr exhibits a high binding affinity for BM matrix. To further
investigate this distribution pattern, a bone/BM-on-a-chip sys-
tem (Figure 7A) was used to model in vivo exposure to dissolved
(non-particulate) Co and Cr in vitro, in order to validate their in-
tegration into cancellous bone and BM matrix also after short-
term (subacute) exposure. Bone/BM-on-a-chip cultures were ex-
posed to divalent Co and trivalent Cr ions at a concentration
each of 2.5 mg L−1 in the microfluidic system for 20 days. Cor-
responding non-exposed bone/BM-on-a-chip cultures served as
controls.
Confocal fluorescence imaging of in vitro cultured scaffolds
revealed an intact cellular layer on the trabecular surface in the
absence of Co and Cr ions and diffuse DNA deposits and non-
intact actin cytoskeletons following exposure to Co and Cr ions
(Figure 7B). Lactate dehydrogenase (LDH) release was used as a
surrogate marker for cytotoxicity and revealed an elevated LDH
release in cell media supernatants of the exposed bone/BM-on-
a-chip culture over the culture period (Figure 7C). The increased
LDH concentration together with the observed cell morpholog-
ical changes seen by 3D imaging of trabeculae are indicative
of cytotoxic effects after subacute exposure to soluble Co and
Cr.
Overview micro-XRF mapping at a spatial resolution of 30 µm
and the distribution of the signal intensity frequency clearly indi-
cated higher Cr signals in exposed culture compared to the con-
trol (Figure 7D). In contrast, a higher Co signal was not detected
in the bone trabeculae nor in the intertrabecular space of the ex-
posed culture. Micro-XRF analyses at higher resolution, showed
that Cr accumulates in the intertrabecular matrix (Figure 7E).
Thresholding, equal to the ex vivo analyses revealed exposure
in the intertrabecular space, in bone trabeculae and most pro-
nounced at the trabecular edge (Figure 7F). A matrix accumula-
tion or bone integration of Co was not observed at higher reso-
lution. Average XRF-spectra confirmed Co background in both
scaffolds which is comparable to the background found in the ex
vivo control samples and prove the Cr accumulation (Figure 7G).
Micro-XRF mapping (Figure 7G) and high-resolution nano-XRF
mapping (Figure 7H) confirmed the in vivo finding that Cr has
a high bone and BM matrix binding affinity. In summary, the
bone/BM-on-a-chip culture shows that exposure to dissolved Co
and Cr at clinically relevant concentrations leads to direct cyto-
toxic effects and confirms the integration of Cr into cancellous
bone and binding to intertrabecular matrix.
3. Discussion
Particulate and non-particulate metals released from endopros-
theses are abundantly represented in peri-implant cancellous
bone and intertrabecular BM. The spatially resolved elemental
analyses, performed in this study, in the micron- and nanorange,
provide unique insights regarding concentration, distribution,
location, and accumulation of metallic degradation products in
peri-implant bone and BM. These results shed new light on the
local toxicokinetics of wear and corrosion products and highlight
the urgent need for bone and BM-specific risk benefit evaluation
of implant materials.
Supraphysiological amounts of Co and Cr were detected in
the peri-implant BM of patients with hip resurfacing implant
or TKA implant. It is well known that hip resurfacing implants
are predisposed to local release and systemic distribution of high
Co and Cr quantities.[26] The pronounced Co and Cr exposure
in the BM per se, exposure in the peri-implant BM of patients
with knee endoprostheses and the distinct differences between
Co and Cr regarding the local kinetics are novel findings. Cr was
found in the particulate state in the micron- and nanoscale. In-
terestingly, in the particulate state Cr was found to be exclusively
co-localized with Co and nanoresolved images of micron-sized
particles depict Cr-rich coronas of these particles pointing on a
release of Cr from the edges of these particles. This finding is
in line with previous elemental analyses of the chemical speci-
ation of CoCr particles within the peri-implant membrane de-
tecting Cr(III) salts and oxides to surround the particles.[27] In
the BM, Cr distinctively accumulates within reticular and cellu-
lar structures. The high amounts of non-particulate Cr point to
binding affinity to the local connective tissue. The pronounced
co-localization of non-particulate Cr with phosphorus and sulfur
suggests its binding to anionic structures of matrix molecules.
Possible binding partners are glycosaminoglycans with polyan-
ionic side chains such as chondroitin sulfate and keratan sul-
fate, which are abundantly represented in the connective tissue
of the BM.[28] The ability of Cr(III) to bind collagen-rich con-
nective tissue structures and thereby denature and preserve ex-
tracellular matrix by cross-linking has been used for centuries
in chrome tanning of leather. This mechanisms could be as-
sumed to occur when comparing the results presented here with
a recent study on Cr binding in leather.[29] Moreover, Cr(III) is
capable of covalent interactions with cellular macromolecules
such as extracellular phospholipids.[30] The specific cellular or
extracellular biomolecules to which Cr binds to in the BM can-
not be conclusively answered by XRF-analyses. However, BM
structures seem to be prone to Cr binding since classical tox-
icokinetic studies in rodents show the most significant reten-
tion of Cr in this tissue.[31] Cr(III) phosphate has been shown
to be the most commonly detected corrosion product in the
peri-implant membrane.[32] In the future, XANES analyses could
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Figure 7. Exposure simulation in a bone/BM-on-a-chip system revealed Cr accumulation in bone trabeculae and intertrabecular matrix. A) Microfluidic
chip system with repopulated human cancellous bone. B) Confocal fluorescence (F-actin, nuclei) and second harmonic imaging (type I collagen) of non-
exposed cancellous bone indicates bone lining cells and non-intact cells after Co and Cr exposure (2.5 mg L−1 each). Z-stack: control, 105 µm; exposed
150 µm. C) Lactate dehydrogenase determination (LDH) revealed an increasing LDH release over the experimental period after Co and Cr exposure.
LDH values are depicted as relative values to the LDH values from the non-exposed chip of the corresponding time point. D) Light microscopy images
of the exposed and non-exposed scaffold at day 18 of metal exposure point to matrix presence in the intertrabecular space. Qualitative RGB images
of 30 µm resolved XRF-maps indicate Cr accumulation in the scaffold after exposure to Co and Cr. Quantitative heatmap of Cr signals and frequency
distributions prove the Cr accumulation. E) Spatial view (10 µm resolution) of the thresholding of different regions regarding calcium content. F) Cr
signals and distributions of the quantitative data points indicate distinct Cr accumulation in the intertrabecular matrix and bone trabeculae. Gray areas
indicate region-specific background Cr levels which were defined as all signals below the upper 99.9% quantile (dashed lines) of the control sample.
G) Averaged XRF-spectra indicate Co background in both scaffolds and prove the Cr accumulation. H) Qualitative RGB images of different regions at
2 µm (top image) and 60 nm resolution (bottom image) indicate Cr exposure in bone and bone marrow matrix. Abbreviations: SHI, second harmonic
imaging; LDH, lactate dehydrogenase TbE, trabecular edge; TbC, trabecular core; iTbS, intertrabecular space.
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potentially clarify the additional presence of Cr(III) orthophos-
phate or other inorganic Cr conformations in peri-implant BM.
The distinct binding affinity of Cr(III) was additionally proven by
subacute exposure in a bone and BM on-a-chip system. A clini-
cally relevant Cr concentration of 2.5 mg L−1 [25] led to Cr accu-
mulation in the intertrabecular matrix. The observed quantities
within the matrix after 20 days of exposure were approximately
two magnitudes lower if compared to the ex vivo analyses. This
leads to the possible implication that a constant replenishment
of Cr ions from particle deposits leads to summation effects in
vivo.
Beside Cr, Co was also detected in peri-implant BM at high
abundance. U.S. and European authorities listed Co compounds
that release Co ions in vivo as potential human carcinogens.[33,34]
Since Co ions are classified as potential carcinogens and supra-
physiological quantities of Co could be detected in BM of patients
with endoprostheses, another implication of this work is that Co
exposure in the BM should also be considered when assessing a
potential cancer risk. However, existing literature on the risk of
cancer development following implantation of hip endoprosthe-
ses with MoM pairing is controversial. A current implant registry
studie clearly indicate no evidence for an overall higher cancer
risk in patients with MoM pairings if compared to patients with
non-MoM pairings.[35] Generally, a long time-period from tumor
initiation to progression must be considered in many cancers and
the advanced age of the arthroplasty clientele may mask potential
exposure-related effects. Furthermore, none of the available epi-
demiological studies on a potential cancer risk related to metallic
endoprostheses, has been controlled for the actual exposure, that
is, for systemic and local metal levels.
The main difference in the local kinetics of Co compared to Cr
is that Co was exclusively detected in the particulate state (always
co-localized with Cr) in matrix structures of the BM. This parti-
cle characteristic is in line with results from a study investigating
the elemental composition of wear particles in the peri-implant
membrane of patients with MoM pairings.[27] Interestingly, in the
case of metal release, the ratio of systemic to local levels is higher
for Co than for Cr.[26] Reasons for this are most likely the higher
dissolution capacity of Co, its concomitant lower binding affinity
to matrix molecules and also its distinct binding affinity to sol-
uble transport proteins as albumins and hemoglobin, which are
highly abundant in the BM.[36,37] In contrast, Cr forms deposits in
the local matrix, which are released over a prolonged time period,
whereas Co is characterized by a higher potential for systemic dis-
tribution but also for excretion.[38] These kinetics explain why, in
cases of severe failure of MoM endoprostheses and local metal
release, systemic Co versus Cr levels increase more but also de-
crease faster following revision surgery.[39,40] In addition, Co pas-
sively dissolves more rapidly in comparison to Cr. Nanoresolved
XRF-maps of micron-sized CoCr particles indicate that the Co to
Cr mass ratio is altered toward a lower Co content if compared to
bulk CoCrMo alloy.
Notably, fractions of the locally released Co, Cr, and Ti inte-
grate into the trabecular edge regions of peri-implant cancellous
bone. Co and Cr are able to further integrate into trabecular core
regions especially in proximity of modular stem hip endopros-
theses, while only Co was found to equally distribute within the
trabecular core of bone from the surrounding of different types of
endoprostheses. Classical studies on the toxicokinetics of Co sup-
port our findings regarding Co integration into bone. It has been
shown that Co integrates into trabecular and cortical surfaces.[41]
Studies investigating the Co and Cr content in mineralized ma-
trix in femoral heads collected at revision surgery of hip resur-
facing implants identified an increase of the Co content in peri-
implant bone and a correlation of the Co content with implant
life time.[42,43] This is interesting since these hip resurfacing im-
plants are known to cause osteolytic lesions at higher prevalence
if compared to other hip implant designs.[5,44] Moreover, there is
evidence that dissolved Co interacts with type I collagen, the prin-
ciple protein in bone, by binding to collagen fibrils leading to di-
minished collagen density.[45] In contrast, in vitro exposure to Co
ions in a 3D bone/BM-on-a-chip system did not lead to enhanced
Co integration into bone trabeculae. This indicates that Co inte-
gration into a native bone matrix does not occur passively and
requires active bone remodeling over a longer time period than
in the performed in vitro setting. The identified regions of ex vivo
peri-implant trabeculae with distinct Co integration allow for the
implication that osteoblasts (OBs), osteocytes, and osteoclasts are
directly exposed to Co. This adds weight to the clinical relevance
of many studies investigating the osteogenic and inflammation-
inducing potential of osteoblastic cells following Co exposure in
vitro and the derived implication on its direct involvement in the
pathomechanism of osteolysis.[46-48]
Furthermore, it must be considered that not only Co and Cr
account for the overall metal exposure in peri-implant BM. Par-
ticularly in the adjacent BM of stemmed prostheses and multi-
component revision implants, large quantities of particles con-
sisting of Ti, Ta, and Zr were detected both intracellularly and ex-
tracellularly in the micron-, submicron- and nanorange. Primar-
ily, these metals were detected in fibrotic and necrotic regions of
the peri-implant BM. Necrotic and fibrotic alterations of tissues
are commonly late changes that occur following chronic inflam-
mation. The large quantities of Ti particles in these conditions
suggest that Ti particles are persistent in the BM tissue struc-
tures over a long period of time. Particles consisting of Ti, Ta, and
Zr and their oxides are characterized by high persistency due to
low solubility in vivo and are known to induce chronic inflam-
mation, which is characterized by a non-specific macrophage-
dominated immune response.[49–51] Depending on particle size,
this innate response leads to foreign body reactions or phagocy-
tosis by macrophages.[52] Both processes lead to macrophage ac-
tivation, which consequently induces a pro-inflammatory milieu
and thereby paracrine cellular effects. Proinflammation in prox-
imity to bone is associated with the clinical problem of sterile
peri-implant osteolysis and attributed to reduced osteoblastogen-
esis and increased osteoclastogenesis.[20] Other important biolog-
ical consequences of pronounced exposure to stable particles and
concomitant chronic inflammation in the peri-implant mem-
brane are known to be fibrosis and necrosis.[53] A histopatholog-
ical pattern which was also observable in peri-implant BM sam-
ples analyzed in this study. Biological consequences of exposure
to Ti-containing particles should be systematically analyzed in
vitro and ex vivo at higher sample sizes.
In the course of assessing potential risks associated with Ti-
containing particles released from non-articulating components,
it should be noted that exposure-related biological consequences
not only depend on particle size and solubility but also on par-
ticle morphology and the crystal phase of metal oxides.[54] The
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unexpected result of pronounced exposure to Ti-containing par-
ticles in BM of all mapped peri-implant BM specimens led us
to thoroughly characterize these particles. The analysis of the
chemical and structural state of Ti-containing particles revealed
that TiO2 in the anatase crystal phase dominates over the rutile
phase. Generally, like many metals, Ti and Ti alloys, as used for
orthopedic implants, form an oxide passivation layer on the metal
surface. The ratios of the different TiO2 crystal conformations
thereby depends on pressure, temperature, and chemical envi-
ronment during the formation of the passivation layer.[55,56] High
levels of anatase on the surface of implant materials are likely in-
tentional because in vitro and in vivo studies have shown anatase
layers to be beneficial for osseointegration of the material.[57,58]
However, in vitro and in vivo studies focusing on the risk assess-
ment of nanoparticulate TiO2 showed that exposure to TiO2 in the
anatase state leads to more pronounced inflammatory, cytotoxic
and genotoxic effects when compared to TiO2 particles in other
crystal phases.[59–61] Such effects are the basis for currently on-
going controversial discussions about the reclassification of TiO2
particles by European regulatory authorities. Due to the harmful
effects of TiO2 particles and to the detection of TiO2 particles in
peri-implant BM in our study, we believe in the future it will be
necessary to systematically analyze Ti-based bulk materials that
are currently used in orthopedic implants with respect to their
surface characteristics. Additionally, in depth characterization of
in vivo released particles and their ability to distribute in the hu-
man body is necessary in order to evaluate the Ti exposure-related
risks to patients.
Our results show that supraphysiological quantities of metals
are found in all peri-implant bone and BM samples. Co, Cr, and
Ti dominate the metal exposure in peri-implant BM where the
overall elemental distribution is comparable to that found in the
peri-implant membrane.[62] These results suggest that the peri-
implant membrane is permeable to the products of metallic wear
and corrosion and implies BM and cancellous bone as future tar-
get organs in preclinical testing of implant materials. Preclini-
cal cytotoxicity testing in the course of regulatory approval has
so far been carried out mainly by using immortalized cell lines
in 2D cultures (ISO 10993–5). Possible future regulatory exten-
sions or replacements should include the integration of in vitro
models that better emulate the cellular diversity of the BM.[63]
Moreover, in vivo biocompatibility tests of arthroplasty materials
should be performed at the actual site of implantation in order
to enhance the validity of the results compared to subcutaneous
models. Pathological changes in the peri-implant bone have re-
cently been added to the framework of the histopathological con-
sensus classification.[64] However, a histological classification for
diagnostics of peri-implant BM pathologies is pending. Toxic-
or allergy-induced hypersensitivity reactions have only been de-
scribed for the peri-implant membrane. In case of local expo-
sure, these specific immune responses might also occur beyond
the membrane, since the immune cell compartment of the BM
is complex and known to be a homing site for antigen specific
cells.[65] Effector memory T cells are key players in delayed type
hypersensitivity toward hapten-carrier adducts formed by metal
ions like Co und Ni.[66] Preclinical models, as presented in this
study, are required to emulate the full cell and matrix complex-
ity of peri-implant bone and BM to provide a microenvironment
closer to that found in vivo.
3.1. Limitations of the Study
The data presented here indicate exposure to metals within bone
and BM which were released from various types of endoprosthe-
ses. Due to the complexity of the methods involved, we were only
able to measure relatively few samples resulting in a small sam-
ple size. Additionally a small intra-operatively harvested speci-
men only represents a small part of the overall local exposure,
which does neither allow for comparing exposure-related biolog-
ical alterations between specimens nor for comparing general
clinical advantages versus disadvantages of the analyzed implants
with other implant types. Furthermore, the detected exposure
levels only represent a retrospective snapshot at the time of im-
plant revision, we cannot therefore draw any conclusions about
the clinical course prior to revision surgeries. However, in-depth
analyses of individual exposure scenarios indicate pronounced
metal-specific accumulation in peri-implant bone and BM and a
general similarity between different implant types regarding lo-
cal kinetics of Co, Cr, and metals released from non-articulating
components. We were able to confirm the Cr-specific accumu-
lation within intertrabecular BM matrix and bone trabeculae in
vitro by a 3D bone/BM-on-a-chip system. However, for a future
validation of this in vitro system as a potential preclinical test sys-
tem, it is necessary to confirm this finding with cells and particles
from individual donors at various exposure levels and durations
to emulate the full range of potential variability.
4. Conclusion
The obtained data demonstrate that metals released from vari-
ous arthroplasty implants lead to multi-elemental exposure in
surrounding bone and BM. In summary, Cr distinctively accu-
mulates in matrix structures of peri-implant BM, Co and Cr inte-
grate into the peri-implant cancellous bone and Ti particles were
predominantly found in peri-implant regions of the BM affected
by fibrotic and inflammatory changes.
The rather low oxidative stability of the CoCrMo alloy com-
pared to other implant materials and associated concerns have
led to the development and launch of many alternative implant
materials in recent years. In the field of THA, CoCrMo-free
implants are becoming increasingly important. Long-term data
from implant registries confirm satisfactory results of CoCrMo-
free THA.[67] In TKA, CoCrMo-free implants and corresponding
long-term data are not yet available to the same extent as in THA.
Despite problems regarding local metal dissolution and sys-
temic distribution of Co and Cr ions, local persistency of more
stable debris, that is, consisting of TiO2, must also be considered.
We are convinced that risk-benefit evaluation of medical devices
should not only comprise biocompatibility testing of bulk mate-
rials but also of wear and corrosion products. The findings ob-
tained in this study help to define clinically relevant concentra-
tions and metal specifications and thus to perform more realistic
in vitro testing in the future. There is a distinct need for advanced
approaches that facilitate reliable preclinical testing using cells or
engineered tissues that emulate the peri-implant biology to fur-
ther risk benefit evaluation of current and future implant mate-
rials. This would support keeping implant safety at the highest
possible level.
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5. Experimental Section
Detailed information on chemicals, buffers, and equipment used in the
course of sample harvesting and preparation are listed in Table S3, Sup-
porting Information.
Patient Recruitment and Sample Harvest: Peri-implant cancellous
bone specimens including BM were collected from 14 patients undergoing
aseptic revision surgery of primary or revision arthroplasty implants of the
hip or knee joint. In addition, native non-exposed samples were collected
from seven patients undergoing primary implantation of artificial hip and
knee joints. Six samples served as controls for XRF-imaging. Primary cells
for the bone and BM-on-a-chip culture were isolated from one sample. The
study was approved by the Institutional Review Board (IRB) of the Charité
– Universitätsmedizin Berlin (IRB approval EA1/194/13). All patients gave
written informed consent.
Sample Preparation and Sectioning: After intraoperative sample har-
vesting, the peri-implant samples were fixed, embedded and sectioned
prior to XRF-mapping. In brief, the cancellous bone specimens with
an approximate diameter of 0.5–2 cm were directly placed into 4%
paraformaldehyde solution. Following overnight fixation, the specimens
were washed with phosphate-buffered saline and placed into embedding
cassettes. For dehydrating the specimens, an ascending ethanol gradient
(70%, 80%, 96%, and 100%) was performed for 24 h in each step. After
completing dehydration by incubation with xylene for 3 h, the specimens
were preinfiltrated in methyl methacrylate, which contains 0.5% m/v ben-
zoyl peroxide / dicyclohexyl phthalate, by applying a partial vacuum at 400
mbar for 10 min and then incubation at normal pressure at 4 °C for 3 days.
In addition to the preinfiltrated step, a subsequent 7-day infiltration step
was performed with additional supplementation of 8% m/v poly(methyl
methacrylate). Final embedding of the specimens was performed in a poly-
merization solution consisting of nine parts methyl methacrylate contain-
ing 16% m/v poly(methyl methacrylate) plus 0.6% m/v benzoyl peroxide
/ dicyclohexyl phthalate and one part methyl methacrylate containing 8%
v/v 3,5,N,N-tetramethylaniline and 4% v/v 1-decanethiol. For polymeriza-
tion, a partial vacuum of 400 mbar was applied for 10 min before the spec-
imens were incubated for at least 24 h at 4 °C. The polymer blocks were
sectioned at a rotary microtome with a tungsten carbide blade under con-
stant moistening by 30% ethanol. 10 µm thick sections were prepared for
the XRF-analyses and 7 µm thick section for histological staining. XRF-
sections were placed between two pieces of a 4 µm thin ultralene foil and
dried overnight at room temperature. Sections for histological staining
were glazed with a 20% 2-methoxyethyl acetate in 70% ethanol solution,
covered with polyethylene foil and dried at 60 °C for 48 h under constant
compression.
Histological Staining and Imaging: H&E stainings on separate but ad-
jacent sections were performed to achieve optimal orientation during XRF-
scanning. Standard protocols for plastics removal by 2-methoxyethyl ac-
etate and subsequent H&E staining were performed.[68] Light microscopy
was performed on a Zeiss Axio Scope. All pictures were taken with the use
of a Zeiss Axiocam MRc microscope camera.
Micro-X-Ray Fluorescence Mapping: Multi-elemental XRF-mapping in
the micron scale with a tunable monochromatic energy above the Co K-
edge was performed at beamline ID21 of the European Synchrotron Ra-
diation Facility (ESRF). The experimental setup of this end-station was
adapted as previously described.[69] The ultralen microfoil covered sec-
tions were mounted in custom-made sample holders. An excitation energy
of 7.8 keV was set up to detect the elements Al, P, S, Ca, Cr, Ti, V, Mn, Fe,
and Co. Undulators harmonics were removed using a double mirror with
Ni coating. High monochromaticity was reached by using a double crys-
tal Si220 monochromator. Downstream of the monochromator, the beam
was focused down to ≈0.6 × 0.8 µm2 (vertical × horizontal) using a fixed-
curvature Kirkpatrick–Baez (KB) mirror system. The flux was ≈5 × 1010
photons s−1. A photodiode collecting the XRF from a thin Ti membrane
inserted in the beam path was used to continuously monitor the incom-
ing beam intensity. XRF and scattered radiation were collected with a dis-
persive energy silicon drift detector (SDD) with an active area of 80 mm2
(SGX, Sensortech, Buckinghamshire, UK). Acquisition time per pixel was
100 ms.
Nano-X-Ray Fluorescence Mapping: Multi-elemental XRF-mapping in
the nanoscale was performed at the Beamline ID16B of the ESRF.[70]
The sections previously analyzed at microbeamline ID21 were adhered
to kapton tape and fixed on custom-made XRF-windows. A pink beam
with an energy of 25.6 keV was focused down to ≈60 × 60 nm² (vertical
× horizontal) using KB mirrors with a photon density of ≈1 × 1011 pho-
tons s−1. One seven-element SDD array (Mirion Technologies Inc., San
Ramon, CA, USA) was used to collect XRF. Acquisition time per spectrum
was 150 ms dwell time. In contrast to beamline ID21, ID16B does not op-
erate under vacuum conditions and thus does not allow the detection of
low Z-elements. Count rates of XRF-intensities related to Ca, Ti, V, Cr, Mn,
Fe, Co, Ni, Ta, Sr, Zr, Nb, and Mo were computed.
Micro-X-Ray Absorption Near Edge Structure Analyses: X-ray XANES
spectra were obtained at beamline ID21 as previously described. [71] In
brief, for collecting spectra at the Ti K-edge, the energy of the incoming
beam was scanned from 4.95 to 5.0 keV in increments of 0.5 eV, with ac-
quisition times of 100 ms per energy. Five micro-XANES spectra were col-
lected per point and subsequently averaged and decomposed a through
linear combination fitting of XANES spectra of anatase and rutile reference
spectra.
Isolation and Cultivation of Primary Human Cells: hMSCs, OBs, and
BM mononuclear cells (BMMNCs) were isolated from cancellous bone
and BM aspirate from a patient who underwent primary implantation of
a hip endoprosthesis. In brief, hMSCs were isolated from BM aspirate by
plastic adherence after density centrifugation. MSC isolation and charac-
terization was performed as described previously.[72] OBs were isolated
from diced cancellous bone and characterized as described previously by
others.[73] The cell culture medium for MSCs and OBs was Dulbecco’s
modified Eagle’s medium with 10% fetal calf serum, 5 mm l-alanyl-l-
glutamine and 100 U mL−1 penicillin plus 100 µg mL−1 streptomycin. The
cells were cryoconservated in passage two until thawing and expansion to
passage four and further use for 3D culture. BMMNCs were isolated from
BM aspirate by density centrifugation (Histopaque, 1.077 g mL−1) at 400×
g for 30 min. After centrifugation, the BMMNCs from the interphase were
cryoconservated in RPMI 1640 supplemented with 12.5% human serum
albumin and 10% dimethyl sulfoxide. The cells were thawed in RPMI 1640
supplemented with 10% human AB serum and 25 U mL−1 nuclease prior
to further use for the bone and BM 3D culture.
Bone and Bone Marrow-on-a-chip: Emulating in vivo exposure to Co
and Cr in vitro was realized by bone and BM 3D cell culture in a mi-
crofluidic chip system (HUMIMIC Chip2, TissUse GmbH). The chip de-
sign and the protocol regarding culture conditions was adapted from pre-
viously described work.[63] Modifications of the culture protocol are de-
tailed as follows: Human decellularized cancellous bone[74] was used as
scaffold material. The cell culture media was supplemented with 10% hu-
man AB serum over the whole culture period. 1.5 × 105 human primary
mesenchymal stromal cells and 1.5 × 105 OBs were seeded on cylindrical
scaffolds (5 mm height, 3 mm radius) before culturing under static con-
ditions in osteoinductive media for 5 days. Osteogenic differentiation was
performed as previously described for 2D culture of mesenchymal stromal
cells.[75] The scaffolds were transferred into the HUMIMIC Chip2 and dy-
namic microfluidic culture was started (day 0). BMMNCs (1.0 × 106) were
seeded on the scaffolds before osteoclastogeneses was induced for 7 days
by growth factor supplementation as described in in vitro culture protocols
for 2D osteoclast differentiation.[76] Growth factor dosimetry was adapted
for the 3D culture protocol. Another 2.0 × 106 BMMNCsc were seeded on
the scaffold (day 7) before culturing for 20 days without any further growth
factor supplementation. Exposure to divalent Co and trivalent Cr was per-
formed as previously described.[25] Metal exposure was initiated at day 8
by a media concentration of 2.5 mg L−1 Co(II) plus 2.5 mg L−1 Cr(III). Ex-
posure was sustained at every media change. After 20 days of dynamic 3D
culture (day 28), the scaffolds were fixed and prepared for XRF-analyses as
described for the ex vivo samples.
Confocal Fluorescence and Second Harmonic Imaging Microscopy: Con-
focal and second harmonic microscopy was performed on a Leica
SP5 II microscope equipped with a Spectra Physics Multiphoton Laser
(Mai Tai HP) using a 25× water immersion objective as described
before.[77]
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Cytotoxicity Assay: Semiquantitative detection of LDH was per-
formed by using a commercially available cytotoxicity detection kit
(Roche) according to the manufacturer’s instructions at every media
change.
Data Presentation and Statistics: XRF- and XANES-spectra were fitted
using the software PyMca.[78] To assess absolute and relative mass frac-
tions, the spectra of regions allocated to cells were averaged and the peak
areas corresponding to individual XRF-lines were computed into mass
fractions, taking into account the matrix composition. The overall den-
sity was assumed to be 1.2 g cm−3 for intertrabecular soft tissue and 1.9 g
cm−3 for bone trabeculae.[79] Low matrix components were assessed to be
0.5 g (carbon), 0.21 g (oxygen), 0.14 g (hydrogen), and 0.17 g (nitrogen)
per cm3.[80,81] PyMca was used for descriptive statistics regarding RGB
imaging, heat maps, and peak spectra. ImageJ was used for the threshold-
ing of the Ca-maps and for reconstruction of the 3D two-photon excitation
images. GraphPad Prism 8.0.0 was used for statistical analysis and data
plotting. No samples or data were excluded from the analysis and all data
points are shown as individual values. The Shapiro–Wilk test was used to
test normality and the Levene test was used to assess the homogeneity
of variances of the data for the indicated groups. Independent and non-
normal distributed data were analyzed using the Mann–Whitney U-test
(two sample groups). If normality could be assumed, unpaired Student’s t-
test (two sample groups) was chosen to determine statistical significance.
Sample size was not predetermined by statistical methods. Analyses of
Pearson correlation coefficients were used to assess the linear correlation
between metal integration from BM into trabecular bone. All tests were
analyzed two-sided and p < 0.05 was regarded as significant. Detailed in-
formation about error bars, sample sizes per group, and statistical analysis
are included in all figure legends. Randomization was not applied and the
investigators were not blinded to group allocation during the experiments
because samples from revision surgery often display obvious morpholog-
ical differences.
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